Antibody Drug Conjugate Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020 - 2030

  • Single User License $3500

Antibody Drug Conjugate Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020 - 2030

Status : October, 2021 | Pharmaceutical

Report Digest


Antibody Drug Conjugate Market: Overview

The antibody drug conjugate market is extrapolated to observe stable growth during the forecast period of 2020-2030. High cancer prevalence is one of the major factors which will influence the growth of the antibody drug conjugate market to a considerable extent.

Unhealthy lifestyle is on the rise across the globe. Due to this lifestyle, many people are obese, a prime reason for cancer. Research reveals that excess fat in the body could serve as an invitation to various types of cancer with uterine, kidney, esophageal, pancreatic, colorectal, and post-menopausal breast being the prominent ones.

Furthermore, elderly people are also at a high risk for cancer. Thus, the rising geriatric population is also an important indicator of growth. All these factors serve as growth generators for the antibody drug conjugate market.

Antibody drug conjugates are biopharmaceutical drugs used for treating certain types of diseases. They are significantly used in cancer treatment. They comprise three components: a cytotoxic agent to eliminate cancer cells, a specific antibody for binding, and a chemical linker to connect the cytotoxic agent to the antibody. The fusion of these components increases its potency, eventually boosting the growth prospects. The utilization in treating breast cancer, urothelial cancrer, blood cancer, and bladder cancer will bring steady growth opportunities for the global market.

TMR Research has covered various aspects related to the growth of the antibody drug conjugate market in the report. The report mentions about numerous aspects that will lead the stakeholder to extensive success. Furthermore, the report reveals the threats and weaknesses of the antibody drug conjugate market to make the stakeholders and the CXOs aware so that they can plan their future business strategies accordingly. The COVID-19 impact has also been included in the report for more clarity on the current situation.

Antibody Drug Conjugate Market: Competitive Insights

The antibody drug conjugate market has diverse players that are involved in fierce competition. Research and development activities form the crux of the growth structure. The research activities lead to new discoveries and treatment options, eventually adding value to the growth of the antibody drug conjugate market.

Strategic collaborations also have a major part in the overall growth of the antibody drug conjugate market. The players collaborate with research institutes and other entities to strengthen their research and development activities. Furthermore, the development of antibody drug conjugate with novel formulations also has a massive role in improving the growth trajectory.

Some well-entrenched players in the antibody drug conjugate market are Daiichi Sankyo Company Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc., ADC Therapeutics, AstraZeneca, Seagen, Inc.and Takeda Pharmaceutical Company Ltd.

Antibody Drug Conjugate Market: Recent Developments

Some recent developments are as follows:

  • The Food and Drug Adminsitration (FDA) granted Fast Track designation for STRO-001, an antibody drug conjugate for treating primary peritoneal cancer.
  • Two grants were recently issued by the National Institute of Health (NIH) totaling more than US$ 1.3 Mn focusing on antibody drug conjugate technology research.

These developments signal the growing influence of the antibody drug conjugates and bode well for the growth of the global market.

Antibody Drug Conjugate Market: Regional Dimensions

The antibody drug conjugate market in North America is prognosticated to observe a dominating position between 2020 and 2030. The rising cases of cancer in the region coupled with increased awareness about antibody drug conjugate treatment will prove to be vital growth factors. Asia Pacific is also anticipated to record accelerating growth for the antibody drug conjugate market due to an increase in the research and development activities in the region.

The reports at TMR Research provide qualitative solutions that break the barriers of doubt or uncertainties when the stakeholders plan to expand their growth reach. The researchers compile the necessary information that enlightens the CXOs about the current growth opportunities in a specific market and enables them to make the most of the opportunities.

TMR Research is a leader in developing well-researched reports. The expertise of the researchers at TMR Research makes the report stand out from others. TMR Research reports help the stakeholders and CXOs make impactful decisions through a unique blend of innovation and analytical thinking. The use of innovation and analytical thinking while structuring a report assures complete and ideal information of the current status of the market to the stakeholders.

TMR Research has rich experience in developing state-of-the-art reports for a wide array of markets and sectors. The brilliance of the experts at TMR Research and their alacrity to conduct thorough research and create phenomenal reports makes TMR Research better than others.

5-Point Growth Formula

The 5-point growth formula developed by TMR Research provides an insight to the stakeholders and CXOs about the current situation in the market. The growth formula makes the report a perfect companion for the stakeholders and CXOs.

The 5-point growth formula includes the following points:

  • Current and Future Threats
  • Accurate Trend Analysis
  • Regional Assessment
  • Industrial Analogy
  • COVID-19 Impact

Current and Future Threats

Along with studying the opportunities necessary for growth, threats are also an important aspect to look upon for the companies and stakeholders in a specific sector. TMR Research studies every negative aspect that will hinder the growth of a specific area of business and includes it in the report. The stakeholders and CXOs will have the benefit of assessing the threat and take the necessary steps to prevent the hindrance caused due to the threats.

Accurate Trend Analysis

Keeping up with the latest trends is crucial in any business or sector. While stakeholders are aware of the trends that are on the surface, TMR Researchers find trends that are deeply entrenched in the particular market or sector. The reports are constantly updated with the latest trends so that the stakeholders and CXOs can derive benefits from the trends and generate good revenues.

Regional Assessment

Demography forms an important part of the growth pattern of all the markets. Diving deep into the demographics enables maximum output from specific areas. The TMR Research team assesses every region and picks out the vital points that have a large impact on the growth of a market.

Industrial Analogy

The analysts at TMR Research conduct an all-round analysis on the competitive landscape of the market. The observations recorded by the analysts are added to the reports so that every stakeholder gets a glimpse of the competitive scenario and frame their business plans according to the situation.

COVID-19 Impact

The COVID-19 outbreak has changed the growth projections of numerous sectors and businesses. The analysts at TMR Research have conducted a conscientious survey on the markets after the pandemic struck. The analysts have put forth their brilliant and well-researched opinions in the report. The opinions will help the stakeholders to plan their strategy accordingly.

The reports offer answers to the top 7 questions that revolve around the growth of the market

  • What are the diverse growth parameters influencing the market?
  • Which regions will contribute largely to the growth of the market
  • What are the recent innovations and technological advancements in the market?
  • What are the emerging trends across the market?
  • How has COVID-19 affected the market?
  • What will be the post-pandemic scenario of the market?
  • What are the major threats that will dent the growth prospects of the market?